Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
8
- Premium Statistic Top therapeutic classes by global pharmaceutical sales 2018 estimates
- Premium Statistic Pharmaceutical industry - sales growth by therapeutic classes
- Basic Statistic Sales of the top pharmaceutical therapeutic areas
- Premium Statistic Sales growth of pharmaceutical therapeutic areas
- Premium Statistic Global pharmaceutical product launches by therapy area 2004-2013
- Basic Statistic Revenue share of Roche's Pharmaceuticals division by therapy area 2013-2023
- Basic Statistic Top pharmaceutical manufacturer vs. top pharmaceutical distributor U.S. 2019
- Premium Statistic Median length of orphan and non-orphan drugs in phase III trial 2015
About the region
7
- Basic Statistic Top pharmaceutical products by sales worldwide 2023
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Basic Statistic AstraZeneca's revenue from Crestor by region 2018-2023
- Premium Statistic Annual growth in global revenue for prescribed orphan drugs 2011-2024
- Premium Statistic Availability of new medicines in selected countries 2013
- Premium Statistic Aspirin tablet price
- Premium Statistic World's top manufacturers of generic drugs based on revenue 2007
Selected statistics
8
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
Other regions
10
- Premium Statistic Required number of patients for phase III trials of orphan and non-orphan drugs 2015
- Basic Statistic Public drug program spending in Canada by top 10 drug classes 2022
- Premium Statistic New products developed by high-tech companies in China 2022, by industry
- Basic Statistic Number of users of prescription drugs in Norway by ATC main group 2021
- Premium Statistic Parapharmaceuticals sales in Russia 2019-2020, by product
- Premium Statistic ATMP registered trials number globally 1999-2015
- Basic Statistic Export value of medicinal and pharmaceutical products in Denmark 2010-2023
- Premium Statistic Massachusetts' medical cannabis spending 2018-2024
- Basic Statistic Pharmaceutical sector expenditure forecast worldwide by country 2060
- Premium Statistic Latin America: per capita sales of OTC medicines 2017, by country
Related statistics
8
- Basic Statistic Leading orphan drugs in development based on net present value 2024
- Premium Statistic Sanofi number of employees 2009-2023
- Premium Statistic Merck & Co.'s top-selling drugs 2023
- Premium Statistic AstraZeneca's revenue from top product Crestor 2006-2023
- Premium Statistic AbbVie's key product revenues 2022-2023
- Premium Statistic Distribution of Roche's Pharmaceuticals division revenues 2014-2023
- Premium Statistic Roche Group's total sales by division 2013-2023
- Premium Statistic Global spending on medicines 2010-2027
Further related statistics
9
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
Further Content: You might find this interesting as well
Statistics
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
IQVIA. (January 31, 2019). Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018* [Graph]. In Statista. Retrieved May 23, 2024, from https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
IQVIA. "Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*." Chart. January 31, 2019. Statista. Accessed May 23, 2024. https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
IQVIA. (2019). Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*. Statista. Statista Inc.. Accessed: May 23, 2024. https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
IQVIA. "Global Spending Growth in Selected Pharmaceutical Major Therapeutic Classes between 2014 and 2018*." Statista, Statista Inc., 31 Jan 2019, https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
IQVIA, Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018* Statista, https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/ (last visited May 23, 2024)
Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018* [Graph], IQVIA, January 31, 2019. [Online]. Available: https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/